Merck Frosst

Patients & Caregivers Contact Us Français

FOSAMAX^®

Press Releases

Product Monograph / Prescribing Information / Product Information

Studies

FACT Study: New Study Comparing Weekly Osteoporosis Treatments Shows FOSAMAX® Demonstrated Significantly Greater Increases in Bone Mineral Density and Reductions in Markers of Bone Turnover than Actonel®

Study Fact Sheet

Patient Preference Of Once Weekly Or Daily Administration Of Alendronate (Fosamax) For Osteoporosis: A Randomized Cross-Over Study

Alendronate* 70 Mg Once Weekly And Alendronate 10 Mg Once Daily Preference Study In Postmenopausal Women With Osteoporosis

Disease Fact Sheets

Backgrounder On Osteoporosis

Product Fact Sheets

FOSAMAX® (alendronate sodium)

Photos

Photos - Click on thumbnail images to enlarge photos

B-Roll

Sept 19, 2002

If you wish to receive a copy of the b-roll, please contact our Public Relations Department at (514) 428-3494.

What's New

Zostavax^MC approved in Canada. The first and only vaccine for the prevention of shingles.

Contact

Media contacts.

Printer friendly

This site is for residents of Canada. / This site was updated on December 11th, 2008.